Our site uses cookies to make navigation as functional as possible, including "third party" cookies and "profiling cookies" designed to tailor on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your consent to some or all cookies, click here. If you proceed browsing this website, you will be consenting to the use of all cookies.

Values in action

Everyday we put our values into action. 10 values, which have given life to Menarini and have shaped its history.
All of us are part of them and act them out by constantly applying the values to our daily practices.
People are at the heart of Menarini's values.

Discover all of Menarini’s initiatives.To enter the heart of our values select the value and read the articles.

A Correct Use of our Products for Patient Safety. One of our goals.

Pharmacovigilance encompasses the activities connected with the ongoing evaluation of information on the safety of medicinal products, with a view to guaranteeing that they can be used by patients who need them with a favourable risk-benefit ratio.
Pharmacovigilance emerged from the need to extend the surveillance of the safety and tolerance of a drug even after its discovery and development, in order to monitor the effects when it is used on a large scale.
In adherence to the regulations in force, Menarini is constantly engaged in the evaluation of reports of suspected adverse reactions to the medicinal products present in Europe, Africa, Asia, Central and South America.
This is why we have set up the Central Drug Safety Unit in the Florence headquarters, to deal with the “centralised” collection of the information originating from all the places where the medicinal products of the Group are used. Then, as regards abroad, each of our foreign affiliates has a Local Drug Safety Unit which, pursuant to the regulations in force in that country, gathers the data relating to all the suspected adverse reactions which come to its knowledge. It then proceeds to forward these data in real time to the central unit of the Group, where all the information is brought together in a global database. This mechanism makes it possible to elaborate analyses that enable a constant, ongoing risk-benefit analysis for each drug.

Whenever a variation in the safety profile is detected, the specific corrective actions are decided and implemented. Where particularly significant problems are identified, it may even be decided to suspend production or to withdraw the medicinal product from the market.




To work at Menarini means to make difference, every day.



Concession granted by Italian Ministry for Cultural Heritage and Activities Read more

Menarini Baby


Our company nursery school for children aged 3 months to 3 years.